Comparison of hypertension prevalence and the use of renin-angiotensin-aldosterone system blockers in hospitalized patients with COVID-19 and non-COVID-19 viral pneumonia
Guardado en:
Autores principales: | Selçuk Görmez, Ceyda Erel Kırışoğlu, Mehmet Erkan Ekicibaşı, Aleks Değirmencioğlu, Ashok Paudel, Gökçe Akan, Fatmahan Atalar, Nevin Sarıgüzel, Burak Pamukçu |
---|---|
Formato: | article |
Lenguaje: | EN TR |
Publicado: |
KARE Publishing
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cebb9f03edce42c5af55f2bf6803abda |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
COVID-19 pathophysiology may be driven by an imbalance in the renin-angiotensin-aldosterone system
por: Susanne Rysz, et al.
Publicado: (2021) -
The Renin–Angiotensin–Aldosterone System and Coronavirus Disease 2019
por: Eliecer Coto, et al.
Publicado: (2021) -
COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure
por: Eftychios Siniorakis, et al.
Publicado: (2020) -
Editorial: New Trends in the Renin-Angiotensin-Aldosterone System in Cardiovascular Disease
por: Ewa Szczepanska-Sadowska, et al.
Publicado: (2021) -
Comparisons of plasma aldosterone and renin data between an automated chemiluminescent immunoanalyzer and conventional radioimmunoassays in the screening and diagnosis of primary aldosteronism.
por: Naohisa Tamura, et al.
Publicado: (2021)